Literature DB >> 18086805

Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages.

John J Lazarus1, Maria A Kay, Akisha L McCarter, R Mark Wooten.   

Abstract

Although it is capable of eliciting strong innate and adaptive immune responses, Borrelia burgdorferi often evades immune clearance through largely unknown mechanisms. Our previous studies determined that infected interlukin-10-/- (IL-10-/-) mice show significantly lower B. burgdorferi levels than wild-type (B6) mice and that IL-10 inhibits innate immune responses critical for controlling B. burgdorferi infection. To determine whether virulent B. burgdorferi preferentially enhances IL-10 production, we developed an in vitro coculture medium (RPMI.B) in which both B. burgdorferi and primary macrophages (Mphis) remain viable. B. burgdorferi grew at similar rates and was able to regulate expression of immunoreactive proteins with similar kinetics in RPMI.B and in traditional BSK medium; in contrast, B. burgdorferi cultured in conventional tissue culture medium (RPMI) rapidly lost viability. Coculture of viable B. burgdorferi in RPMI.B with Mphis resulted in more rapid and significant increases in IL-10 transcripts and secreted proteins than coculture with nonviable B. burgdorferi in RPMI, which corresponded with decreased production of proinflammatory cytokines. Addition of live B. burgdorferi to Mphis in RPMI.B also elicited substantially higher IL-10 levels than heat-killed bacteria elicited, confirming that increased IL-10 production was not inherent to coculture in RPMI.B. Transfer of supernatants from B. burgdorferi-stimulated Mphis into naïve Mphi cultures resulted in suppressed activation upon subsequent stimulation with different bacterial agonists, and this suppression was obviated by IL-10-specific antibody. In vivo analyses determined that murine skin samples exhibited substantial upregulation of IL-10 within 24 h of injection of B. burgdorferi. Together, these results suggest that viable B. burgdorferi can suppress early Mphi responses during infection by causing increased release of IL-10.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086805      PMCID: PMC2258815          DOI: 10.1128/IAI.01404-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.

Authors:  P McGuirk; K H Mills
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

2.  Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

Authors:  Sudhanshu Agrawal; Anshu Agrawal; Barbara Doughty; Andrew Gerwitz; John Blenis; Thomas Van Dyke; Bali Pulendran
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

Review 3.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

4.  A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi.

Authors:  S Casjens; N Palmer; R van Vugt; W M Huang; B Stevenson; P Rosa; R Lathigra; G Sutton; J Peterson; R J Dodson; D Haft; E Hickey; M Gwinn; O White; C M Fraser
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

5.  Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins.

Authors:  P K Murthy; V A Dennis; B L Lasater; M T Philipp
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10.

Authors:  S Thoma-Uszynski; S M Kiertscher; M T Ochoa; D A Bouis; M V Norgard; K Miyake; P J Godowski; M D Roth; R L Modlin
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

7.  MyD88 plays a unique role in host defense but not arthritis development in Lyme disease.

Authors:  Devin D Bolz; Rhianna S Sundsbak; Ying Ma; Shizuo Akira; Carsten J Kirschning; James F Zachary; John H Weis; Janis J Weis
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

8.  Tripalmitoyl-S-glyceryl-cysteine-dependent OspA vaccination of toll-like receptor 2-deficient mice results in effective protection from Borrelia burgdorferi challenge.

Authors:  Alyson Yoder; Xiaohui Wang; Ying Ma; Mario T Philipp; Marta Heilbrun; John H Weis; Carsten J Kirschning; R Mark Wooten; Janis J Weis
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice.

Authors:  Nengyin Liu; Ruth R Montgomery; Stephen W Barthold; Linda K Bockenstedt
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway.

Authors:  Y Ma; K P Seiler; K F Tai; L Yang; M Woods; J J Weis
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  24 in total

1.  The BBA33 lipoprotein binds collagen and impacts Borrelia burgdorferi pathogenesis.

Authors:  Hui Zhi; Eric H Weening; Elena Magda Barbu; Jenny A Hyde; Magnus Höök; Jon T Skare
Journal:  Mol Microbiol       Date:  2015-01-30       Impact factor: 3.501

2.  Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation.

Authors:  Aarti Gautam; Saurabh Dixit; Mario T Philipp; Shree R Singh; Lisa A Morici; Deepak Kaushal; Vida A Dennis
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 3.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

4.  CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection.

Authors:  Rebecca A Elsner; Christine J Hastey; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

5.  Treponema denticola suppresses expression of human {beta}-defensin-3 in gingival epithelial cells through inhibition of the toll-like receptor 2 axis.

Authors:  Ji Eun Shin; Young Sook Kim; Ju-Eun Oh; Byung-Moo Min; Youngnim Choi
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

6.  Borrelia burgdorferi arthritis-associated locus Bbaa1 regulates Lyme arthritis and K/B×N serum transfer arthritis through intrinsic control of type I IFN production.

Authors:  Ying Ma; Kenneth K C Bramwell; Robert B Lochhead; Jackie K Paquette; James F Zachary; John H Weis; Cory Teuscher; Janis J Weis
Journal:  J Immunol       Date:  2014-11-05       Impact factor: 5.422

7.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Differentiated THP-1 Cells Exposed to Pathogenic and Nonpathogenic Borrelia Species Demonstrate Minimal Differences in Production of Four Inflammatory Cytokines.

Authors:  John V Stokes; Gail M Moraru; Chelsea McIntosh; Evangel Kummari; Keiko Rausch; Andrea S Varela-Stokes
Journal:  Vector Borne Zoonotic Dis       Date:  2016-09-28       Impact factor: 2.133

9.  Interval-specific congenic lines reveal quantitative trait Loci with penetrant lyme arthritis phenotypes on chromosomes 5, 11, and 12.

Authors:  Ying Ma; Jennifer C Miller; Hillary Crandall; Eric T Larsen; Diane M Dunn; Robert B Weiss; Meenakumari Subramanian; John H Weis; James F Zachary; Cory Teuscher; Janis J Weis
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

10.  The caspase 1 inflammasome is not required for control of murine Lyme borreliosis.

Authors:  Nengyin Liu; Alexia A Belperron; Carmen J Booth; Linda K Bockenstedt
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.